Nutrition and wellness company HealthKart has crossed the ₹2,000 crore revenue mark in FY26, with its profit before tax rising 30%, according to Entrackr’s analysis of its consolidated annual statements sourced from the Registrar of Companies, reported on 28 October 2026. It is a scale-plus-profitability story that stands out in startup funding in India, where growth at any cost has given way to growth that pays.

Revenue from operations rose 56.2% to ₹2,052 crore in FY26 from ₹1,313 crore in FY25. Product sales remained the main driver, accounting for nearly 99% of operating revenue, rising 59.2% to ₹2,033 crore from ₹1,279 crore. Including other income of ₹54 crore, total income rose to ₹2,106 crore from ₹1,368 crore.

Profit up, but costs climbed too

Profit before tax, excluding exceptional items, rose 30% to ₹124 crore from ₹95 crore in FY25. That improvement came despite a sharp rise in costs: total expenses grew 55.7% to ₹1,982 crore. Procurement, the largest cost, jumped 71.9% to ₹1,071 crore, while advertising and marketing spending rose 53.2% to ₹403 crore. Employee benefits, commissions, freight and other overheads made up the rest of the increase.

HealthKart owns and operates a portfolio of nutrition and wellness brands including MuscleBlaze, The Protein Zone, TrueBasics, HK Vitals, bGreen, Nouriza and Gritzo. The company has raised around $382 million in funding to date, with Peak XV Partners, Temasek and Sofina among its investors, and Entrackr notes it is reportedly gearing up for an IPO — a claim that remains unconfirmed, but one that a ₹2,000-crore, profitable revenue base would support.

The lesson in the numbers

HealthKart’s FY26 shows the trade-off consumer founders live with: marketing and procurement costs rose almost as fast as revenue, yet the business still widened its absolute profit. Scale did the work — a bigger base absorbed the cost inflation. For founders chasing a public listing, that combination of scale, brand portfolio depth and sustained profitability is exactly the profile IPO investors look for.

Why it matters for founders

Profitability is not the opposite of growth — at scale, it is the proof of it. HealthKart spent heavily on marketing and still grew profit 30%, because its revenue base was large enough to absorb it. Build the base first, then let operating leverage do its work.